International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 3 May-June 2024 Submit your research before last 3 days of June to publish your research paper in the issue of May-June.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 3
May-June 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Risk Associated with Antibiotic in Irritable Bowel Syndrome (IBS), Role of Microbiota and Future Aspects

Author(s) Tonushyam Sonowal, Chinmoyee Deori, Leena Hujuri, Daisy Narzari, Dr. Jesim Ali Ahmed
Country India
Abstract Irritable bowel syndrome (IBS) is functional gastrointestinal (GI) disorder that characterized by abdominal pain in relation to disturbed bowel habits. It is a substantial burden on both patient health –related quality of life and healthcare cost. Although various path physiologic mechanisms have been formulated including visceral hypersensitivity, altered bowel motility, gut- brain dysregulations but it is believed that gut microbiome plays an important role in the genesis of symptoms. The composition and diversity of the gut micro biota can be modified by use of antibiotics, as they have the capacity to diminish the levels of advantageous bacteria while allowing the proliferation of detrimental bacteria. It is well known that micro biome takes a crucial role in development of IBS, but antibiotics itself is a potential risk factors for IBS has not been clarified yet. However, lack of highly predictive diagnostics biomarkers and the complexity and the heterogeneity of IBS patients make management difficult and unsatisfactory in most of the cases, thereby reducing patient health- related quality of life and increasing the sanitary burden. So, this review would help us to understand the risk factors associated with antibiotics in developing IBS, the role of gut micro biome and the other potential future approaches which are useful for the diagnosis, prevention and treatment of irritable bowel syndrome.
Keywords Irritable bowel syndrome (IBS), Gut microbiota, Antibiotic risk
Field Medical / Pharmacy
Published In Volume 6, Issue 1, January-February 2024
Published On 2024-02-23
Cite This Risk Associated with Antibiotic in Irritable Bowel Syndrome (IBS), Role of Microbiota and Future Aspects - Tonushyam Sonowal, Chinmoyee Deori, Leena Hujuri, Daisy Narzari, Dr. Jesim Ali Ahmed - IJFMR Volume 6, Issue 1, January-February 2024. DOI 10.36948/ijfmr.2024.v06i01.13916
DOI https://doi.org/10.36948/ijfmr.2024.v06i01.13916
Short DOI https://doi.org/gtjtts
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 3 Cover Page Vol 6 Isu 2 Cover Page Vol 6 Isu 1

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com